
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature
Juliëtte Pouw, Emmerik F A Leijten, Timothy R. D. J. Radstake, et al.
Clinical Immunology (2019) Vol. 211, pp. 108318-108318
Open Access | Times Cited: 21
Juliëtte Pouw, Emmerik F A Leijten, Timothy R. D. J. Radstake, et al.
Clinical Immunology (2019) Vol. 211, pp. 108318-108318
Open Access | Times Cited: 21
Showing 21 citing articles:
Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
Annie Ren, Eleftherios P. Diamandis, Vathany Kulasingam
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100155-100155
Open Access | Times Cited: 59
Annie Ren, Eleftherios P. Diamandis, Vathany Kulasingam
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100155-100155
Open Access | Times Cited: 59
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
Céleste J T van der Togt, Bart J. F. van den Bemt, Daniel Aletaha, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002898-e002898
Open Access | Times Cited: 16
Céleste J T van der Togt, Bart J. F. van den Bemt, Daniel Aletaha, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002898-e002898
Open Access | Times Cited: 16
A self-management intervention for newly diagnosed with inflammatory arthritis: a randomized controlled feasibility and fidelity study
Luise Holberg Lindgren, Tanja Thomsen, Merete Lund Hetland, et al.
Pilot and Feasibility Studies (2025) Vol. 11, Iss. 1
Open Access
Luise Holberg Lindgren, Tanja Thomsen, Merete Lund Hetland, et al.
Pilot and Feasibility Studies (2025) Vol. 11, Iss. 1
Open Access
Pathological significance of sex hormones (testosterone and estrogen) associated with pro-inflammatory cytokines (IL-12, IL-17A, and IL-23) in patients with psoriasis and psoriatic arthritis
Randa R. Ghamyes, Abdul Kareem A. AL-Kazaz
Revista Colombiana de Reumatología (2025)
Closed Access
Randa R. Ghamyes, Abdul Kareem A. AL-Kazaz
Revista Colombiana de Reumatología (2025)
Closed Access
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis
Mohammad Reza Pourani, Fahimeh Abdollahimajd, Omid Zargari, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 1967-1974
Closed Access | Times Cited: 26
Mohammad Reza Pourani, Fahimeh Abdollahimajd, Omid Zargari, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 1967-1974
Closed Access | Times Cited: 26
Cytokine profile characterization of naïve patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum
Piero Ruscitti, Maria Esposito, Ilenia Di Cola, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Piero Ruscitti, Maria Esposito, Ilenia Di Cola, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis
Oliver FitzGerald, Stephen R. Pennington
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 3, pp. 123-124
Closed Access | Times Cited: 13
Oliver FitzGerald, Stephen R. Pennington
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 3, pp. 123-124
Closed Access | Times Cited: 13
Combined – whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment
Alexandros Grivas, Maria Grigoriou, Nikos Malissovas, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Alexandros Grivas, Maria Grigoriou, Nikos Malissovas, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Disease activity indices in psoriatic arthritis: current and evolving concepts
Chrysoula G. Gialouri, G. Fragoulis
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4427-4435
Closed Access | Times Cited: 13
Chrysoula G. Gialouri, G. Fragoulis
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4427-4435
Closed Access | Times Cited: 13
Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors
A. Makos, Jan Herman Kuiper, Oksana Kehoe, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 77-87
Open Access | Times Cited: 9
A. Makos, Jan Herman Kuiper, Oksana Kehoe, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 77-87
Open Access | Times Cited: 9
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential
Michael J. Grayling, Theophile Bigirumurame, Svetlana Cherlin, et al.
BMC Rheumatology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Michael J. Grayling, Theophile Bigirumurame, Svetlana Cherlin, et al.
BMC Rheumatology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 12
Using knockoffs for controlled predictive biomarker identification
Konstantinos Sechidis, Matthías Kormáksson, David Ohlssen
Statistics in Medicine (2021) Vol. 40, Iss. 25, pp. 5453-5473
Closed Access | Times Cited: 12
Konstantinos Sechidis, Matthías Kormáksson, David Ohlssen
Statistics in Medicine (2021) Vol. 40, Iss. 25, pp. 5453-5473
Closed Access | Times Cited: 12
Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study
Maria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Maria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial
Stefan Siebert, G. Schett, S. P. Raychaudhuri, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access | Times Cited: 1
Stefan Siebert, G. Schett, S. P. Raychaudhuri, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access | Times Cited: 1
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
Philippa D. K. Curry, Andrew P. Morris, Anne Barton, et al.
The Pharmacogenomics Journal (2022) Vol. 23, Iss. 1, pp. 1-7
Open Access | Times Cited: 7
Philippa D. K. Curry, Andrew P. Morris, Anne Barton, et al.
The Pharmacogenomics Journal (2022) Vol. 23, Iss. 1, pp. 1-7
Open Access | Times Cited: 7
Early intervention in psoriasis: Where do we go from here?
Paulo Antonio Oldani Félix, Ana Luísa Sampaio, Bruno Leonardo Silva, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Paulo Antonio Oldani Félix, Ana Luísa Sampaio, Bruno Leonardo Silva, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Factors predicting treatment response to biological and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review and meta-analysis
T. Künzler, Monika Bamert, Haiko Sprott
Clinical Rheumatology (2024)
Open Access
T. Künzler, Monika Bamert, Haiko Sprott
Clinical Rheumatology (2024)
Open Access
Early psoriatic arthritis: when is the right time to start advanced therapy?
Or Hen, Stephanie Harrison, Gabriele De Marco, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Or Hen, Stephanie Harrison, Gabriele De Marco, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Innovative Trial Approaches in Immune-Mediated Inflammatory Diseases: Current Use and Future Potential
Michael J. Grayling, Theophile Bigirumurame, Svetlana Cherlin, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Michael J. Grayling, Theophile Bigirumurame, Svetlana Cherlin, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Real-world data provide insights into PsA treatment patterns
Helena Marzo‐Ortega, Stephanie Harrison
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 8, pp. 466-467
Closed Access
Helena Marzo‐Ortega, Stephanie Harrison
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 8, pp. 466-467
Closed Access
Letting go of the dichotomy between psoriasis and psoriatic arthritis
Emmerik F A Leijten
(2021)
Open Access
Emmerik F A Leijten
(2021)
Open Access